Raltegravir potassium salt ≥98%, crystalline solid

Supplier: Cayman Chemical
Danger

Synonyms: Raltegravir potassium, Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate

16071-10 16071-1 16071-50 16071-5
CAYM16071-10EA 399 GBP
CAYM16071-10 CAYM16071-1 CAYM16071-50 CAYM16071-5
Raltegravir potassium salt ≥98%, crystalline solid
Raltegravir potassium salt

Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).


It is metabolised primarily by uridine diphosphate glucuronosyltransferase 1A1. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.

Formula: C₂₀H₂₀FKN₆O₅
MW: 482,51 g/mol
Storage Temperature: Refrigerator
MDL Number: MFCD12031642
CAS Number: 871038-72-1

Order Now

Specification Test Results

Purity ≥98%
λmax 210, 312 nm

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR